Preprint Article Version 1 This version is not peer-reviewed

Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double Knockout Mice

Xueqin Gao
* ORCID logo ,
Yan Cui
,
Greg Zhang
,
Joseph J Ruzbarsky
,
Bing Wang
,
Jonathan E Layne
,
Xiang Xiao
,
Johnny Huard
*
Version 1 : Received: 3 November 2024 / Approved: 4 November 2024 / Online: 4 November 2024 (10:06:12 CET)

How to cite: Gao, X.; Cui, Y.; Zhang, G.; Ruzbarsky, J. J.; Wang, B.; Layne, J. E.; Xiao, X.; Huard, J. Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double Knockout Mice. Preprints 2024, 2024110141. https://doi.org/10.20944/preprints202411.0141.v1 Gao, X.; Cui, Y.; Zhang, G.; Ruzbarsky, J. J.; Wang, B.; Layne, J. E.; Xiao, X.; Huard, J. Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double Knockout Mice. Preprints 2024, 2024110141. https://doi.org/10.20944/preprints202411.0141.v1

Abstract

Duchenne muscular dystrophy (DMD) is a severe genetic muscle disease due to mutations of dystrophin gene. There is no cure for DMD. Using a dystrophin-/-utrophin-/- (DKO-Hom) mouse model, we investigated the PGE2/EP2 pathway in the pathogenesis of dystrophic muscle and its potential as a therapeutic target. We found that Ep2, Ep4, Cox-2, 15-Pgdh mRNA, and PGE2 are significantly increased in DKO-Hom mice compared to wild-type (WT) mice. The EP2 and EP4 receptors are mainly expressed in CD68+ macrophages and are significantly increased in the muscle tissues of both dystrophin-/- (mdx) and DKO-Hom mice compared to WT mice. Osteogenic and osteoclastogenic gene expression in skeletal muscle also increased in DKO-Hom mice, which correlates with severe muscle heterotopic ossification (HO). Treatment of DKO-Hom mice with the EP2 antagonist PF04418948 for 2 weeks, increased body weight, reduced HO and muscle pathology by decreasing both total macrophages (CD68+) and senescent macrophages (CD68+P21+), while increasing endothelial cells (CD31+). PF04418948 also increased bone volume/total volume (BV/TV), trabecular thickness (Tb.Th) of the tibia trabecular bone and the cortical bone thickness of both the femur and tibia without affecting spine trabecular bone microarchitecture. In summary, our results indicate that targeting EP2 improves muscle pathology and maintains bone mass.

Keywords

muscular dystrophy; EP2; EP4; PGE2; bone microarchitecture; heterotopic ossification; PF04418948

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.